BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang JY, Wang XK, Zhu GZ, Zhou X, Yao J, Ma XP, Wang B, Peng T. Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma. BMC Cancer 2021;21:462. [PMID: 33902495 DOI: 10.1186/s12885-021-08104-z] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Jiang D, Zhang Y, Wang Y, Xu F, Liang J, Wang W. Diagnostic accuracy and prognostic significance of Glypican-3 in hepatocellular carcinoma: A systematic review and meta-analysis. Front Oncol 2022;12:1012418. [DOI: 10.3389/fonc.2022.1012418] [Reference Citation Analysis]
2 Liu Y, Ren H, Yang M, Li J, Chen L. GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-15. [DOI: 10.1155/2022/8209700] [Reference Citation Analysis]
3 Zhang S, Jing J, Meng L, Xu B, Ma X, Tian W. Peptide-Conjugated Aggregation-Induced Emission Fluorogenic Probe for Glypican-3 Protein Detection and Hepatocellular Carcinoma Cells Imaging. Chemosensors 2022;10:195. [DOI: 10.3390/chemosensors10050195] [Reference Citation Analysis]
4 Wang H, Yu S, Cai Q, Ma D, Yang L, Zhao J, Jiang L, Zhang X, Yu Z. The Prognostic Model Based on Tumor Cell Evolution Trajectory Reveals a Different Risk Group of Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:737723. [PMID: 34660596 DOI: 10.3389/fcell.2021.737723] [Cited by in F6Publishing: 2] [Reference Citation Analysis]